nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—CYP2D6—Alzheimer's disease	0.442	1	CbGaD
Midodrine—CYP2D6—Rivastigmine—Alzheimer's disease	0.152	0.432	CbGbCtD
Midodrine—CYP2D6—Donepezil—Alzheimer's disease	0.121	0.345	CbGbCtD
Midodrine—CYP2D6—Galantamine—Alzheimer's disease	0.0782	0.223	CbGbCtD
Midodrine—Micturition urgency—Donepezil—Alzheimer's disease	0.00385	0.0221	CcSEcCtD
Midodrine—Melatonin—MT3—Alzheimer's disease	0.00362	0.518	CrCbGaD
Midodrine—Micturition urgency—Rivastigmine—Alzheimer's disease	0.00342	0.0196	CcSEcCtD
Midodrine—Hepatic enzyme increased—Galantamine—Alzheimer's disease	0.00298	0.0171	CcSEcCtD
Midodrine—Cramps of lower extremities—Galantamine—Alzheimer's disease	0.00259	0.0148	CcSEcCtD
Midodrine—Vasodilation—Donepezil—Alzheimer's disease	0.00248	0.0142	CcSEcCtD
Midodrine—Vasodilation procedure—Donepezil—Alzheimer's disease	0.00248	0.0142	CcSEcCtD
Midodrine—Hepatic enzyme increased—Memantine—Alzheimer's disease	0.00209	0.012	CcSEcCtD
Midodrine—Cramps of lower extremities—Donepezil—Alzheimer's disease	0.002	0.0115	CcSEcCtD
Midodrine—Urinary retention—Galantamine—Alzheimer's disease	0.00194	0.0112	CcSEcCtD
Midodrine—Cramps of lower extremities—Rivastigmine—Alzheimer's disease	0.00178	0.0102	CcSEcCtD
Midodrine—Melatonin—CALM1—Alzheimer's disease	0.00172	0.247	CrCbGaD
Midodrine—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00169	0.00972	CcSEcCtD
Midodrine—Sleep disorder—Memantine—Alzheimer's disease	0.00166	0.00953	CcSEcCtD
Midodrine—Hepatic function abnormal—Memantine—Alzheimer's disease	0.00165	0.00944	CcSEcCtD
Midodrine—Pollakiuria—Galantamine—Alzheimer's disease	0.00163	0.00936	CcSEcCtD
Midodrine—Sleep disorder—Rivastigmine—Alzheimer's disease	0.00163	0.00932	CcSEcCtD
Midodrine—Irritability—Donepezil—Alzheimer's disease	0.00151	0.00867	CcSEcCtD
Midodrine—Urinary retention—Donepezil—Alzheimer's disease	0.00151	0.00864	CcSEcCtD
Midodrine—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00149	0.00855	CcSEcCtD
Midodrine—Dry skin—Donepezil—Alzheimer's disease	0.00145	0.00833	CcSEcCtD
Midodrine—Bradycardia—Galantamine—Alzheimer's disease	0.00144	0.00826	CcSEcCtD
Midodrine—Urinary tract disorder—Galantamine—Alzheimer's disease	0.0014	0.00801	CcSEcCtD
Midodrine—Urethral disorder—Galantamine—Alzheimer's disease	0.00139	0.00795	CcSEcCtD
Midodrine—Irritability—Memantine—Alzheimer's disease	0.00137	0.00788	CcSEcCtD
Midodrine—Urinary retention—Memantine—Alzheimer's disease	0.00137	0.00785	CcSEcCtD
Midodrine—Urinary retention—Rivastigmine—Alzheimer's disease	0.00134	0.00768	CcSEcCtD
Midodrine—Dry skin—Memantine—Alzheimer's disease	0.00132	0.00756	CcSEcCtD
Midodrine—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00131	0.00753	CcSEcCtD
Midodrine—Flushing—Galantamine—Alzheimer's disease	0.00131	0.00753	CcSEcCtD
Midodrine—Cardiac disorder—Galantamine—Alzheimer's disease	0.00131	0.00753	CcSEcCtD
Midodrine—Dry skin—Rivastigmine—Alzheimer's disease	0.00129	0.0074	CcSEcCtD
Midodrine—Angiopathy—Galantamine—Alzheimer's disease	0.00128	0.00736	CcSEcCtD
Midodrine—Dysuria—Donepezil—Alzheimer's disease	0.00128	0.00734	CcSEcCtD
Midodrine—Pollakiuria—Donepezil—Alzheimer's disease	0.00126	0.00726	CcSEcCtD
Midodrine—Mental disorder—Galantamine—Alzheimer's disease	0.00124	0.00711	CcSEcCtD
Midodrine—Flatulence—Galantamine—Alzheimer's disease	0.00121	0.00696	CcSEcCtD
Midodrine—Tension—Galantamine—Alzheimer's disease	0.00121	0.00693	CcSEcCtD
Midodrine—Nervousness—Galantamine—Alzheimer's disease	0.0012	0.00686	CcSEcCtD
Midodrine—Back pain—Galantamine—Alzheimer's disease	0.00119	0.00683	CcSEcCtD
Midodrine—Muscle spasms—Galantamine—Alzheimer's disease	0.00118	0.00679	CcSEcCtD
Midodrine—Dysuria—Memantine—Alzheimer's disease	0.00116	0.00667	CcSEcCtD
Midodrine—Pollakiuria—Memantine—Alzheimer's disease	0.00115	0.00659	CcSEcCtD
Midodrine—Dysuria—Rivastigmine—Alzheimer's disease	0.00114	0.00652	CcSEcCtD
Midodrine—Agitation—Galantamine—Alzheimer's disease	0.00113	0.00649	CcSEcCtD
Midodrine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00112	0.00644	CcSEcCtD
Midodrine—Bradycardia—Donepezil—Alzheimer's disease	0.00112	0.0064	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.0011	0.0063	CcSEcCtD
Midodrine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00108	0.00621	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00107	0.00617	CcSEcCtD
Midodrine—Urethral disorder—Donepezil—Alzheimer's disease	0.00107	0.00616	CcSEcCtD
Midodrine—Hypertension—Galantamine—Alzheimer's disease	0.00106	0.0061	CcSEcCtD
Midodrine—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00105	0.00601	CcSEcCtD
Midodrine—Anxiety—Galantamine—Alzheimer's disease	0.00104	0.00599	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00104	0.00597	CcSEcCtD
Midodrine—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00103	0.00588	CcSEcCtD
Midodrine—Dry mouth—Galantamine—Alzheimer's disease	0.00102	0.00588	CcSEcCtD
Midodrine—Confusional state—Galantamine—Alzheimer's disease	0.00101	0.00581	CcSEcCtD
Midodrine—Bradycardia—Memantine—Alzheimer's disease	0.00101	0.00581	CcSEcCtD
Midodrine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000991	0.00568	CcSEcCtD
Midodrine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000985	0.00565	CcSEcCtD
Midodrine—Chills—Donepezil—Alzheimer's disease	0.000983	0.00564	CcSEcCtD
Midodrine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000983	0.00564	CcSEcCtD
Midodrine—Tachycardia—Galantamine—Alzheimer's disease	0.00098	0.00562	CcSEcCtD
Midodrine—Skin disorder—Galantamine—Alzheimer's disease	0.000976	0.0056	CcSEcCtD
Midodrine—Urethral disorder—Memantine—Alzheimer's disease	0.000975	0.0056	CcSEcCtD
Midodrine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000961	0.00551	CcSEcCtD
Midodrine—Mental disorder—Donepezil—Alzheimer's disease	0.00096	0.00551	CcSEcCtD
Midodrine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000954	0.00547	CcSEcCtD
Midodrine—Erythema multiforme—Memantine—Alzheimer's disease	0.000941	0.0054	CcSEcCtD
Midodrine—Flatulence—Donepezil—Alzheimer's disease	0.00094	0.00539	CcSEcCtD
Midodrine—Melatonin—MPO—Alzheimer's disease	0.000937	0.134	CrCbGaD
Midodrine—Tension—Donepezil—Alzheimer's disease	0.000936	0.00537	CcSEcCtD
Midodrine—Nervousness—Donepezil—Alzheimer's disease	0.000926	0.00532	CcSEcCtD
Midodrine—Flushing—Memantine—Alzheimer's disease	0.000923	0.0053	CcSEcCtD
Midodrine—Cardiac disorder—Memantine—Alzheimer's disease	0.000923	0.0053	CcSEcCtD
Midodrine—Back pain—Donepezil—Alzheimer's disease	0.000923	0.00529	CcSEcCtD
Midodrine—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00092	0.00528	CcSEcCtD
Midodrine—Muscle spasms—Donepezil—Alzheimer's disease	0.000917	0.00526	CcSEcCtD
Midodrine—Insomnia—Galantamine—Alzheimer's disease	0.000909	0.00521	CcSEcCtD
Midodrine—Flushing—Rivastigmine—Alzheimer's disease	0.000903	0.00518	CcSEcCtD
Midodrine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000903	0.00518	CcSEcCtD
Midodrine—Angiopathy—Memantine—Alzheimer's disease	0.000903	0.00518	CcSEcCtD
Midodrine—Paraesthesia—Galantamine—Alzheimer's disease	0.000902	0.00518	CcSEcCtD
Midodrine—Somnolence—Galantamine—Alzheimer's disease	0.000893	0.00512	CcSEcCtD
Midodrine—Chills—Memantine—Alzheimer's disease	0.000893	0.00512	CcSEcCtD
Midodrine—Dyspepsia—Galantamine—Alzheimer's disease	0.000884	0.00507	CcSEcCtD
Midodrine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000883	0.00507	CcSEcCtD
Midodrine—Agitation—Donepezil—Alzheimer's disease	0.000877	0.00503	CcSEcCtD
Midodrine—Chills—Rivastigmine—Alzheimer's disease	0.000873	0.00501	CcSEcCtD
Midodrine—Mental disorder—Memantine—Alzheimer's disease	0.000872	0.005	CcSEcCtD
Midodrine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000867	0.00498	CcSEcCtD
Midodrine—Flatulence—Memantine—Alzheimer's disease	0.000853	0.0049	CcSEcCtD
Midodrine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000853	0.00489	CcSEcCtD
Midodrine—Tension—Memantine—Alzheimer's disease	0.00085	0.00488	CcSEcCtD
Midodrine—Nervousness—Memantine—Alzheimer's disease	0.000841	0.00483	CcSEcCtD
Midodrine—Back pain—Memantine—Alzheimer's disease	0.000838	0.00481	CcSEcCtD
Midodrine—Flatulence—Rivastigmine—Alzheimer's disease	0.000835	0.00479	CcSEcCtD
Midodrine—Tension—Rivastigmine—Alzheimer's disease	0.000831	0.00477	CcSEcCtD
Midodrine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000828	0.00475	CcSEcCtD
Midodrine—Hypertension—Donepezil—Alzheimer's disease	0.000824	0.00472	CcSEcCtD
Midodrine—Nervousness—Rivastigmine—Alzheimer's disease	0.000823	0.00472	CcSEcCtD
Midodrine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000821	0.00471	CcSEcCtD
Midodrine—Back pain—Rivastigmine—Alzheimer's disease	0.00082	0.0047	CcSEcCtD
Midodrine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000815	0.00467	CcSEcCtD
Midodrine—Anxiety—Donepezil—Alzheimer's disease	0.000809	0.00464	CcSEcCtD
Midodrine—Agitation—Memantine—Alzheimer's disease	0.000796	0.00457	CcSEcCtD
Midodrine—Dry mouth—Donepezil—Alzheimer's disease	0.000794	0.00456	CcSEcCtD
Midodrine—Abdominal pain—Galantamine—Alzheimer's disease	0.000794	0.00456	CcSEcCtD
Midodrine—Confusional state—Donepezil—Alzheimer's disease	0.000785	0.0045	CcSEcCtD
Midodrine—Agitation—Rivastigmine—Alzheimer's disease	0.000779	0.00447	CcSEcCtD
Midodrine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000763	0.00438	CcSEcCtD
Midodrine—Hypertension—Memantine—Alzheimer's disease	0.000748	0.00429	CcSEcCtD
Midodrine—Anxiety—Memantine—Alzheimer's disease	0.000735	0.00422	CcSEcCtD
Midodrine—Hypertension—Rivastigmine—Alzheimer's disease	0.000731	0.0042	CcSEcCtD
Midodrine—Dry mouth—Memantine—Alzheimer's disease	0.000721	0.00414	CcSEcCtD
Midodrine—Asthenia—Galantamine—Alzheimer's disease	0.000721	0.00414	CcSEcCtD
Midodrine—Anxiety—Rivastigmine—Alzheimer's disease	0.000719	0.00412	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000716	0.00411	CcSEcCtD
Midodrine—Confusional state—Memantine—Alzheimer's disease	0.000713	0.00409	CcSEcCtD
Midodrine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000705	0.00405	CcSEcCtD
Midodrine—Insomnia—Donepezil—Alzheimer's disease	0.000704	0.00404	CcSEcCtD
Midodrine—Melatonin—ESR1—Alzheimer's disease	0.000703	0.101	CrCbGaD
Midodrine—Paraesthesia—Donepezil—Alzheimer's disease	0.000699	0.00401	CcSEcCtD
Midodrine—Confusional state—Rivastigmine—Alzheimer's disease	0.000697	0.004	CcSEcCtD
Midodrine—Dyspnoea—Donepezil—Alzheimer's disease	0.000694	0.00398	CcSEcCtD
Midodrine—Nervous system disorder—Memantine—Alzheimer's disease	0.000693	0.00398	CcSEcCtD
Midodrine—Somnolence—Donepezil—Alzheimer's disease	0.000692	0.00397	CcSEcCtD
Midodrine—Tachycardia—Memantine—Alzheimer's disease	0.00069	0.00396	CcSEcCtD
Midodrine—Skin disorder—Memantine—Alzheimer's disease	0.000687	0.00394	CcSEcCtD
Midodrine—Dyspepsia—Donepezil—Alzheimer's disease	0.000685	0.00393	CcSEcCtD
Midodrine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000678	0.00389	CcSEcCtD
Midodrine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000675	0.00387	CcSEcCtD
Midodrine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000672	0.00386	CcSEcCtD
Midodrine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000672	0.00385	CcSEcCtD
Midodrine—Pain—Donepezil—Alzheimer's disease	0.000666	0.00382	CcSEcCtD
Midodrine—Dizziness—Galantamine—Alzheimer's disease	0.000664	0.00381	CcSEcCtD
Midodrine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000642	0.00368	CcSEcCtD
Midodrine—Insomnia—Memantine—Alzheimer's disease	0.000639	0.00367	CcSEcCtD
Midodrine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000637	0.00365	CcSEcCtD
Midodrine—Paraesthesia—Memantine—Alzheimer's disease	0.000635	0.00364	CcSEcCtD
Midodrine—Rash—Galantamine—Alzheimer's disease	0.000633	0.00363	CcSEcCtD
Midodrine—Dermatitis—Galantamine—Alzheimer's disease	0.000633	0.00363	CcSEcCtD
Midodrine—Dyspnoea—Memantine—Alzheimer's disease	0.00063	0.00362	CcSEcCtD
Midodrine—Headache—Galantamine—Alzheimer's disease	0.000629	0.00361	CcSEcCtD
Midodrine—Somnolence—Memantine—Alzheimer's disease	0.000628	0.00361	CcSEcCtD
Midodrine—Insomnia—Rivastigmine—Alzheimer's disease	0.000625	0.00359	CcSEcCtD
Midodrine—Dyspepsia—Memantine—Alzheimer's disease	0.000622	0.00357	CcSEcCtD
Midodrine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000621	0.00356	CcSEcCtD
Midodrine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000616	0.00354	CcSEcCtD
Midodrine—Abdominal pain—Donepezil—Alzheimer's disease	0.000615	0.00353	CcSEcCtD
Midodrine—Somnolence—Rivastigmine—Alzheimer's disease	0.000615	0.00353	CcSEcCtD
Midodrine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00061	0.0035	CcSEcCtD
Midodrine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000609	0.00349	CcSEcCtD
Midodrine—Pain—Memantine—Alzheimer's disease	0.000604	0.00347	CcSEcCtD
Midodrine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000597	0.00343	CcSEcCtD
Midodrine—Nausea—Galantamine—Alzheimer's disease	0.000597	0.00342	CcSEcCtD
Midodrine—Pain—Rivastigmine—Alzheimer's disease	0.000591	0.00339	CcSEcCtD
Midodrine—Feeling abnormal—Memantine—Alzheimer's disease	0.000582	0.00334	CcSEcCtD
Midodrine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000578	0.00332	CcSEcCtD
Midodrine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00057	0.00327	CcSEcCtD
Midodrine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000565	0.00324	CcSEcCtD
Midodrine—Abdominal pain—Memantine—Alzheimer's disease	0.000559	0.00321	CcSEcCtD
Midodrine—Asthenia—Donepezil—Alzheimer's disease	0.000559	0.0032	CcSEcCtD
Midodrine—Pruritus—Donepezil—Alzheimer's disease	0.000551	0.00316	CcSEcCtD
Midodrine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000547	0.00314	CcSEcCtD
Midodrine—Dizziness—Donepezil—Alzheimer's disease	0.000515	0.00295	CcSEcCtD
Midodrine—Asthenia—Memantine—Alzheimer's disease	0.000507	0.00291	CcSEcCtD
Midodrine—Pruritus—Memantine—Alzheimer's disease	0.0005	0.00287	CcSEcCtD
Midodrine—Asthenia—Rivastigmine—Alzheimer's disease	0.000496	0.00285	CcSEcCtD
Midodrine—Rash—Donepezil—Alzheimer's disease	0.000491	0.00282	CcSEcCtD
Midodrine—Dermatitis—Donepezil—Alzheimer's disease	0.00049	0.00281	CcSEcCtD
Midodrine—Pruritus—Rivastigmine—Alzheimer's disease	0.000489	0.00281	CcSEcCtD
Midodrine—Headache—Donepezil—Alzheimer's disease	0.000488	0.0028	CcSEcCtD
Midodrine—ADRA1D—forebrain—Alzheimer's disease	0.000475	0.118	CbGeAlD
Midodrine—Dizziness—Memantine—Alzheimer's disease	0.000467	0.00268	CcSEcCtD
Midodrine—Nausea—Donepezil—Alzheimer's disease	0.000462	0.00265	CcSEcCtD
Midodrine—Dizziness—Rivastigmine—Alzheimer's disease	0.000457	0.00262	CcSEcCtD
Midodrine—Rash—Memantine—Alzheimer's disease	0.000446	0.00256	CcSEcCtD
Midodrine—Dermatitis—Memantine—Alzheimer's disease	0.000445	0.00255	CcSEcCtD
Midodrine—Headache—Memantine—Alzheimer's disease	0.000443	0.00254	CcSEcCtD
Midodrine—ADRA1D—telencephalon—Alzheimer's disease	0.000437	0.108	CbGeAlD
Midodrine—Rash—Rivastigmine—Alzheimer's disease	0.000436	0.0025	CcSEcCtD
Midodrine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000436	0.0025	CcSEcCtD
Midodrine—Headache—Rivastigmine—Alzheimer's disease	0.000433	0.00249	CcSEcCtD
Midodrine—Nausea—Memantine—Alzheimer's disease	0.00042	0.00241	CcSEcCtD
Midodrine—Nausea—Rivastigmine—Alzheimer's disease	0.000411	0.00236	CcSEcCtD
Midodrine—ADRA1A—forebrain—Alzheimer's disease	0.000273	0.0677	CbGeAlD
Midodrine—ADRA1B—nervous system—Alzheimer's disease	0.000264	0.0654	CbGeAlD
Midodrine—ADRA1D—nervous system—Alzheimer's disease	0.000258	0.064	CbGeAlD
Midodrine—ADRA1B—central nervous system—Alzheimer's disease	0.000254	0.063	CbGeAlD
Midodrine—ADRA1A—telencephalon—Alzheimer's disease	0.000251	0.0623	CbGeAlD
Midodrine—ADRA1D—central nervous system—Alzheimer's disease	0.000248	0.0616	CbGeAlD
Midodrine—ADRA1B—brain—Alzheimer's disease	0.000201	0.05	CbGeAlD
Midodrine—ADRA1D—brain—Alzheimer's disease	0.000197	0.0489	CbGeAlD
Midodrine—CYP2D6—forebrain—Alzheimer's disease	0.000161	0.0399	CbGeAlD
Midodrine—ADRA1A—nervous system—Alzheimer's disease	0.000148	0.0368	CbGeAlD
Midodrine—CYP2D6—telencephalon—Alzheimer's disease	0.000148	0.0367	CbGeAlD
Midodrine—ADRA1A—central nervous system—Alzheimer's disease	0.000143	0.0354	CbGeAlD
Midodrine—ADRA1A—cerebellum—Alzheimer's disease	0.000139	0.0346	CbGeAlD
Midodrine—ADRA1A—brain—Alzheimer's disease	0.000113	0.0281	CbGeAlD
Midodrine—CYP2D6—nervous system—Alzheimer's disease	8.72e-05	0.0217	CbGeAlD
Midodrine—CYP2D6—central nervous system—Alzheimer's disease	8.39e-05	0.0208	CbGeAlD
Midodrine—CYP2D6—cerebellum—Alzheimer's disease	8.2e-05	0.0204	CbGeAlD
Midodrine—CYP2D6—brain—Alzheimer's disease	6.66e-05	0.0166	CbGeAlD
Midodrine—ADRA1B—Signaling by GPCR—NPS—Alzheimer's disease	2.03e-05	0.000929	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.02e-05	0.000925	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GAL—Alzheimer's disease	2.01e-05	0.000921	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GFAP—Alzheimer's disease	2.01e-05	0.000921	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR6—Alzheimer's disease	2.01e-05	0.00092	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—NPS—Alzheimer's disease	1.98e-05	0.000909	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—NPY—Alzheimer's disease	1.97e-05	0.000903	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.96e-05	0.000898	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IAPP—Alzheimer's disease	1.96e-05	0.000897	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.94e-05	0.000887	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—GAB2—Alzheimer's disease	1.94e-05	0.000887	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—SST—Alzheimer's disease	1.94e-05	0.000887	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CRH—Alzheimer's disease	1.9e-05	0.000871	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—SST—Alzheimer's disease	1.89e-05	0.000867	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—GAB2—Alzheimer's disease	1.89e-05	0.000867	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—APP—Alzheimer's disease	1.89e-05	0.000864	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CCL2—Alzheimer's disease	1.86e-05	0.000851	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CDK5—Alzheimer's disease	1.85e-05	0.000849	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—F2—Alzheimer's disease	1.85e-05	0.000849	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.85e-05	0.000846	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—APP—Alzheimer's disease	1.84e-05	0.000845	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PSENEN—Alzheimer's disease	1.82e-05	0.000836	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—NPS—Alzheimer's disease	1.8e-05	0.000826	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APH1A—Alzheimer's disease	1.8e-05	0.000824	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.79e-05	0.000822	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR6—Alzheimer's disease	1.78e-05	0.000817	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PLCB1—Alzheimer's disease	1.78e-05	0.000815	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—A2M—Alzheimer's disease	1.77e-05	0.000812	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.77e-05	0.000811	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.76e-05	0.000808	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NCSTN—Alzheimer's disease	1.75e-05	0.000802	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.75e-05	0.0008	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.74e-05	0.000798	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—SST—Alzheimer's disease	1.72e-05	0.000788	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—GAB2—Alzheimer's disease	1.72e-05	0.000788	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PSEN2—Alzheimer's disease	1.72e-05	0.000786	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LRP1—Alzheimer's disease	1.71e-05	0.000782	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.7e-05	0.000781	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—APP—Alzheimer's disease	1.68e-05	0.000768	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GAL—Alzheimer's disease	1.67e-05	0.000764	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GFAP—Alzheimer's disease	1.67e-05	0.000764	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CCR5—Alzheimer's disease	1.65e-05	0.000758	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CCL2—Alzheimer's disease	1.65e-05	0.000756	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.65e-05	0.000754	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PSENEN—Alzheimer's disease	1.62e-05	0.000742	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.62e-05	0.000742	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APH1A—Alzheimer's disease	1.6e-05	0.000732	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PRKCG—Alzheimer's disease	1.59e-05	0.000727	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PLCB1—Alzheimer's disease	1.58e-05	0.000724	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NPY—Alzheimer's disease	1.58e-05	0.000723	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IAPP—Alzheimer's disease	1.57e-05	0.000719	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NCSTN—Alzheimer's disease	1.56e-05	0.000713	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CRH—Alzheimer's disease	1.52e-05	0.000698	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LRP1—Alzheimer's disease	1.52e-05	0.000695	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCR5—Alzheimer's disease	1.5e-05	0.000688	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GFAP—Alzheimer's disease	1.48e-05	0.000679	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GAL—Alzheimer's disease	1.48e-05	0.000679	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—HTR2A—Alzheimer's disease	1.47e-05	0.000674	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—A2M—Alzheimer's disease	1.47e-05	0.000674	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.46e-05	0.000671	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.45e-05	0.000664	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NPS—Alzheimer's disease	1.44e-05	0.000662	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PPP3CA—Alzheimer's disease	1.44e-05	0.000658	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PSEN2—Alzheimer's disease	1.42e-05	0.000652	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—F2—Alzheimer's disease	1.42e-05	0.00065	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PTK2B—Alzheimer's disease	1.42e-05	0.000649	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GAB2—Alzheimer's disease	1.38e-05	0.000631	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SST—Alzheimer's disease	1.38e-05	0.000631	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NTRK2—Alzheimer's disease	1.38e-05	0.000631	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CCR5—Alzheimer's disease	1.37e-05	0.000629	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CALM1—Alzheimer's disease	1.37e-05	0.000629	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GSK3A—Alzheimer's disease	1.37e-05	0.000626	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.34e-05	0.000616	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APP—Alzheimer's disease	1.34e-05	0.000615	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PRKCG—Alzheimer's disease	1.32e-05	0.000603	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NPY—Alzheimer's disease	1.31e-05	0.0006	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—A2M—Alzheimer's disease	1.31e-05	0.000598	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IAPP—Alzheimer's disease	1.3e-05	0.000597	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.3e-05	0.000596	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—F2—Alzheimer's disease	1.29e-05	0.000591	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.29e-05	0.00059	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PLCB1—Alzheimer's disease	1.27e-05	0.00058	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PSEN2—Alzheimer's disease	1.26e-05	0.000579	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CRH—Alzheimer's disease	1.26e-05	0.000579	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCR5—Alzheimer's disease	1.25e-05	0.000571	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HTR2A—Alzheimer's disease	1.22e-05	0.000559	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CCR5—Alzheimer's disease	1.22e-05	0.000559	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NPS—Alzheimer's disease	1.2e-05	0.000549	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.19e-05	0.000547	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PPP3CA—Alzheimer's disease	1.19e-05	0.000546	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NGFR—Alzheimer's disease	1.18e-05	0.000541	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—F2—Alzheimer's disease	1.18e-05	0.00054	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PTK2B—Alzheimer's disease	1.18e-05	0.000538	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CREB1—Alzheimer's disease	1.17e-05	0.000538	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PRKCG—Alzheimer's disease	1.17e-05	0.000536	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NPY—Alzheimer's disease	1.16e-05	0.000533	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IAPP—Alzheimer's disease	1.16e-05	0.00053	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADAM10—Alzheimer's disease	1.15e-05	0.000529	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCL2—Alzheimer's disease	1.15e-05	0.000526	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GAB2—Alzheimer's disease	1.14e-05	0.000524	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NTRK2—Alzheimer's disease	1.14e-05	0.000524	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SST—Alzheimer's disease	1.14e-05	0.000524	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CALM1—Alzheimer's disease	1.14e-05	0.000522	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GSK3A—Alzheimer's disease	1.13e-05	0.000519	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CRH—Alzheimer's disease	1.12e-05	0.000514	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APP—Alzheimer's disease	1.11e-05	0.00051	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCR5—Alzheimer's disease	1.11e-05	0.000508	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—S100B—Alzheimer's disease	1.09e-05	0.0005	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HTR2A—Alzheimer's disease	1.08e-05	0.000497	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—F2—Alzheimer's disease	1.07e-05	0.00049	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NPS—Alzheimer's disease	1.06e-05	0.000488	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.06e-05	0.000486	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.06e-05	0.000486	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PPP3CA—Alzheimer's disease	1.06e-05	0.000485	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PLCB1—Alzheimer's disease	1.05e-05	0.000482	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—F2—Alzheimer's disease	1.05e-05	0.00048	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PTK2B—Alzheimer's disease	1.04e-05	0.000478	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IGF2—Alzheimer's disease	1.04e-05	0.000476	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.02e-05	0.000466	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SST—Alzheimer's disease	1.02e-05	0.000465	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NTRK2—Alzheimer's disease	1.02e-05	0.000465	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GAB2—Alzheimer's disease	1.02e-05	0.000465	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CALM1—Alzheimer's disease	1.01e-05	0.000463	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GSK3A—Alzheimer's disease	1.01e-05	0.000461	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IGF1R—Alzheimer's disease	1e-05	0.00046	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APP—Alzheimer's disease	9.9e-06	0.000453	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NGFR—Alzheimer's disease	9.81e-06	0.000449	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	9.79e-06	0.000449	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CREB1—Alzheimer's disease	9.75e-06	0.000447	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LPL—Alzheimer's disease	9.63e-06	0.000441	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADAM10—Alzheimer's disease	9.58e-06	0.000439	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MEF2C—Alzheimer's disease	9.55e-06	0.000437	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCL2—Alzheimer's disease	9.54e-06	0.000437	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—F2—Alzheimer's disease	9.5e-06	0.000435	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—A2M—Alzheimer's disease	9.45e-06	0.000433	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PRKCG—Alzheimer's disease	9.37e-06	0.000429	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PLCB1—Alzheimer's disease	9.34e-06	0.000428	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NGF—Alzheimer's disease	9.12e-06	0.000418	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—S100B—Alzheimer's disease	9.06e-06	0.000415	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCR5—Alzheimer's disease	8.88e-06	0.000407	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NGFR—Alzheimer's disease	8.71e-06	0.000399	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HTR2A—Alzheimer's disease	8.69e-06	0.000398	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	8.66e-06	0.000397	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF2—Alzheimer's disease	8.63e-06	0.000395	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	8.51e-06	0.00039	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	8.47e-06	0.000388	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF1R—Alzheimer's disease	8.34e-06	0.000382	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	8.22e-06	0.000377	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	8.13e-06	0.000373	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CALM1—Alzheimer's disease	8.1e-06	0.000371	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LEP—Alzheimer's disease	8.07e-06	0.00037	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOE—Alzheimer's disease	8.07e-06	0.00037	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	8.05e-06	0.000369	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CAV1—Alzheimer's disease	8e-06	0.000367	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LPL—Alzheimer's disease	8e-06	0.000366	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MEF2C—Alzheimer's disease	7.92e-06	0.000363	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PRKCG—Alzheimer's disease	7.77e-06	0.000356	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ESR1—Alzheimer's disease	7.71e-06	0.000353	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.71e-06	0.000353	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.71e-06	0.000353	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	7.66e-06	0.000351	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—F2—Alzheimer's disease	7.61e-06	0.000349	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NGF—Alzheimer's disease	7.57e-06	0.000347	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NOTCH1—Alzheimer's disease	7.45e-06	0.000341	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	7.41e-06	0.000339	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCR5—Alzheimer's disease	7.37e-06	0.000338	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR2A—Alzheimer's disease	7.21e-06	0.00033	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	7.17e-06	0.000328	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	7.1e-06	0.000325	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	7.04e-06	0.000323	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GSK3B—Alzheimer's disease	6.99e-06	0.00032	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CREB1—Alzheimer's disease	6.94e-06	0.000318	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	6.91e-06	0.000316	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—INS—Alzheimer's disease	6.9e-06	0.000316	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCL2—Alzheimer's disease	6.79e-06	0.000311	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.76e-06	0.00031	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	6.73e-06	0.000308	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CALM1—Alzheimer's disease	6.73e-06	0.000308	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOE—Alzheimer's disease	6.7e-06	0.000307	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LEP—Alzheimer's disease	6.7e-06	0.000307	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IGF1—Alzheimer's disease	6.67e-06	0.000306	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CAV1—Alzheimer's disease	6.64e-06	0.000304	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.55e-06	0.0003	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	6.54e-06	0.0003	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	6.4e-06	0.000293	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ESR1—Alzheimer's disease	6.4e-06	0.000293	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—F2—Alzheimer's disease	6.32e-06	0.00029	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NOTCH1—Alzheimer's disease	6.19e-06	0.000283	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NOS3—Alzheimer's disease	6.05e-06	0.000277	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	5.97e-06	0.000274	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	5.95e-06	0.000273	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	5.95e-06	0.000273	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	5.9e-06	0.00027	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	5.8e-06	0.000266	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	5.76e-06	0.000264	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	5.73e-06	0.000262	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	5.68e-06	0.00026	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.65e-06	0.000259	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	5.63e-06	0.000258	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.62e-06	0.000258	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	5.61e-06	0.000257	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	5.54e-06	0.000254	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	5.49e-06	0.000252	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	5.18e-06	0.000238	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	5.16e-06	0.000236	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.14e-06	0.000236	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	5.14e-06	0.000235	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	5.11e-06	0.000234	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	5.1e-06	0.000234	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	5.09e-06	0.000233	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	5.02e-06	0.00023	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	5e-06	0.000229	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	4.92e-06	0.000225	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	4.72e-06	0.000216	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	4.71e-06	0.000216	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.63e-06	0.000212	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	4.46e-06	0.000204	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	4.36e-06	0.0002	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.33e-06	0.000198	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.31e-06	0.000198	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	4.3e-06	0.000197	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.27e-06	0.000196	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	4.26e-06	0.000195	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	4.24e-06	0.000194	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	4e-06	0.000183	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	3.92e-06	0.00018	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	3.91e-06	0.000179	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.82e-06	0.000175	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	3.79e-06	0.000173	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	3.76e-06	0.000172	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.75e-06	0.000172	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—INS—Alzheimer's disease	3.68e-06	0.000169	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	3.62e-06	0.000166	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	3.48e-06	0.000159	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	3.47e-06	0.000159	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	3.32e-06	0.000152	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	3.29e-06	0.000151	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.23e-06	0.000148	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	3.21e-06	0.000147	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	3.01e-06	0.000138	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.95e-06	0.000135	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.95e-06	0.000135	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	2.78e-06	0.000127	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	2.73e-06	0.000125	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	2.5e-06	0.000115	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	2.43e-06	0.000111	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	2.31e-06	0.000106	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	2.22e-06	0.000102	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	2.05e-06	9.39e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.48e-06	6.8e-05	CbGpPWpGaD
